Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02402660
Brief Title: Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

First Submitted : March 9, 2015
First Submitted that Met QC Criteria : March 27, 2015
First Posted : March 30, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 11, 2019
Last Update Posted : June 13, 2019